127 is the total number of securities HealthInvest Partners AB has owned. The longest HealthInvest Partners AB has owned a single stock is 17 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
CRL | CHARLES RIV LABS INTL INC | 17 | 17 | 5.66% | 8.39% | 12.78% | Q4 2013 | Q4 2017 | 17 |
GILD | GILEAD SCIENCES INC | 7 | 4 | 5.46% | 9.39% | 14.48% | Q2 2014 | Q4 2022 | 16 |
CAH | CARDINAL HEALTH INC | 6 | 1 | 2.37% | 7.76% | 14.84% | Q1 2014 | Q4 2022 | 15 |
ICCC | IMMUCELL CORP | 15 | 15 | 0.19% | 0.62% | 1.66% | Q4 2013 | Q2 2017 | 15 |
MCK | MCKESSON CORP | 8 | 1 | 2.39% | 8.80% | 14.62% | Q4 2013 | Q3 2022 | 14 |
ANTM | ANTHEM INC | 9 | 3 | 5.66% | 9.40% | 14.31% | Q4 2014 | Q4 2017 | 12 |
GTS | TRIPLE-S MGMT CORP | 12 | 12 | 3.58% | 6.21% | 8.70% | Q1 2014 | Q4 2016 | 12 |
LPNT | LIFEPOINT HOSPITALS INC | 11 | 11 | 5.57% | 8.39% | 13.27% | Q4 2013 | Q2 2016 | 11 |
SUPN | SUPERNUS PHARMACEUTICA... | 6 | 4 | 6.14% | 9.30% | 15.46% | Q3 2015 | Q3 2021 | 10 |
ANIK | ANIKA THERAPEUTICS INC | 10 | 10 | 0.77% | 8.38% | 13.04% | Q3 2015 | Q4 2017 | 10 |
ABC | AMERISOURCEBERGEN CORP | 5 | 1 | 0.10% | 7.91% | 17.10% | Q2 2016 | Q4 2022 | 10 |
BMY | BRISTOL-MYERS SQUIBB CO | 9 | 1 | 2.48% | 7.83% | 14.72% | Q4 2017 | Q4 2022 | 10 |
PFE | PFIZER INC | 4 | 1 | 0.12% | 9.42% | 14.49% | Q4 2014 | Q4 2022 | 8 |
MGLN | Magellan Health Svcs Inc | 8 | 8 | 5.94% | 8.29% | 12.78% | Q1 2014 | Q4 2015 | 8 |
AIQ | ALLIANCE HEALTHCARE SR... | 8 | 8 | 3.03% | 7.16% | 9.15% | Q4 2013 | Q3 2015 | 8 |
AET | AETNA INC NEW | 6 | 1 | 5.92% | 10.67% | 17.41% | Q1 2014 | Q1 2017 | 7 |
CI | CIGNA CORP NEW | 4 | 3 | 5.01% | 8.37% | 10.24% | Q4 2020 | Q4 2022 | 7 |
CRY | CRYOLIFE INC | 7 | 7 | 0.52% | 2.58% | 4.17% | Q4 2013 | Q2 2015 | 7 |
IRWD | IRONWOOD PHARMACEUTICA... | 6 | 6 | 6.30% | 12.89% | 18.54% | Q4 2020 | Q1 2022 | 6 |
UTMD | UTAH MED PRODS INC | 6 | 6 | 5.64% | 11.71% | 18.25% | Q3 2021 | Q4 2022 | 6 |
GNCIQ | GNC HLDGS INC | 6 | 6 | 4.30% | 7.45% | 11.99% | Q4 2015 | Q1 2017 | 6 |
ABBV | ABBVIE INC | 5 | 1 | 0.25% | 5.50% | 9.16% | Q4 2020 | Q4 2022 | 6 |
SSRG | SYMMETRY SURGICAL INC | 6 | 6 | 0.51% | 0.92% | 1.46% | Q4 2014 | Q1 2016 | 6 |
BIIB | BIOGEN INC | 3 | 2 | 5.65% | 7.70% | 9.39% | Q2 2017 | Q2 2022 | 5 |
MRK | MERCK & CO INC NEW | 4 | 1 | 0.24% | 5.41% | 7.38% | Q1 2016 | Q4 2022 | 5 |
SKH | SKILLED HEALTHCARE GRO... | 5 | 5 | 3.44% | 4.97% | 8.54% | Q4 2013 | Q4 2014 | 5 |
BASI | BIOANALYTICAL SYS INC | 5 | 5 | 0.22% | 0.40% | 0.58% | Q2 2014 | Q2 2015 | 5 |
HRMY | HARMONY BIOSCIENCES HL... | 4 | 4 | 8.54% | 10.04% | 11.72% | Q3 2021 | Q2 2022 | 4 |
V107SC | WELLPOINT INC | 4 | 4 | 6.94% | 8.78% | 11.27% | Q4 2013 | Q3 2014 | 4 |
ARAY | ACCURAY INC | 4 | 4 | 4.56% | 8.30% | 11.00% | Q4 2020 | Q3 2021 | 4 |
VTRS | VIATRIS INC | 3 | 1 | 6.52% | 8.21% | 10.21% | Q4 2020 | Q4 2022 | 4 |
MDT | MEDTRONIC INC | 4 | 4 | 5.74% | 7.96% | 11.30% | Q4 2013 | Q3 2014 | 4 |
TARO | TARO PHARMACEUTICAL IN... | 4 | 4 | 5.76% | 6.68% | 7.65% | Q1 2016 | Q4 2016 | 4 |
THOR | THORATEC CORP | 4 | 4 | 3.57% | 5.82% | 8.64% | Q4 2013 | Q3 2014 | 4 |
KMPH | KEMPHARM INC | 4 | 4 | 2.04% | 5.44% | 9.89% | Q1 2022 | Q4 2022 | 4 |
LJPC | LA JOLLA PHARMACEUTICA... | 4 | 4 | 1.61% | 5.29% | 9.30% | Q3 2021 | Q2 2022 | 4 |
AMAG | AMAG PHARMACEUTICALS INC | 3 | 3 | 7.37% | 7.62% | 8.11% | Q4 2015 | Q2 2016 | 3 |
FEIC | FEI CO | 3 | 3 | 5.81% | 7.50% | 9.99% | Q4 2015 | Q2 2016 | 3 |
LH | LABORATORY CORP AMER H... | 3 | 3 | 5.99% | 7.42% | 8.80% | Q2 2017 | Q4 2017 | 3 |
LGND | LIGAND PHARMACEUTICALS... | 3 | 3 | 5.84% | 7.32% | 8.51% | Q2 2017 | Q4 2017 | 3 |
ESRX | Express Scripts Hldg Co | 3 | 3 | 4.20% | 7.24% | 11.78% | Q4 2013 | Q2 2014 | 3 |
HOLX | Hologic Inc | 3 | 3 | 4.60% | 6.64% | 8.53% | Q4 2013 | Q2 2014 | 3 |
INCR | INC RESH HLDGS INC | 3 | 3 | 5.00% | 6.22% | 7.39% | Q1 2016 | Q3 2016 | 3 |
CFN | CAREFUSION CORP | 3 | 3 | 5.48% | 6.14% | 6.93% | Q1 2014 | Q3 2014 | 3 |
HRC | Hill Rom Hldgs Inc | 3 | 3 | 5.59% | 6.12% | 6.67% | Q4 2013 | Q2 2014 | 3 |
VRTX | VERTEX PHARMACEUTICALS... | 2 | 1 | 0.12% | 5.35% | 9.94% | Q1 2021 | Q4 2022 | 3 |
OPNT | OPIANT PHARMACEUTICALS... | 3 | 3 | 0.62% | 3.73% | 5.80% | Q1 2022 | Q3 2022 | 3 |
AUPH | AURINIA PHARMACEUTICAL... | 3 | 3 | 1.92% | 3.63% | 5.33% | Q2 2022 | Q4 2022 | 3 |
OSUR | ORASURE TECHNOLOGIES INC | 2 | 1 | 0.73% | 1.13% | 1.37% | Q3 2015 | Q2 2016 | 3 |
SURG | SYNERGETICS USA INC | 3 | 3 | 0.80% | 0.87% | 0.98% | Q4 2014 | Q2 2015 | 3 |
MR | MINDRAY MEDICAL INTL LTD | 2 | 2 | 7.97% | 8.10% | 8.24% | Q4 2014 | Q1 2015 | 2 |
VAR | VARIAN MED SYS INC | 2 | 2 | 7.00% | 7.64% | 8.29% | Q3 2015 | Q4 2015 | 2 |
CHRS | COHERUS BIOSCIENCES INC | 2 | 2 | 6.91% | 7.29% | 7.68% | Q4 2020 | Q1 2021 | 2 |
CVS | CVS HEALTH CORP | 1 | 1 | 5.09% | 7.22% | 9.36% | Q1 2021 | Q4 2022 | 2 |
RIGL | RIGEL PHARMACEUTICALS INC | 2 | 2 | 4.07% | 6.83% | 9.60% | Q3 2021 | Q4 2021 | 2 |
CI | CIGNA CORPORATION | 2 | 2 | 5.74% | 6.71% | 7.68% | Q3 2017 | Q4 2017 | 2 |
MDT | MEDTRONIC PLC | 2 | 2 | 5.83% | 6.64% | 7.46% | Q3 2017 | Q4 2017 | 2 |
WAT | WATERS CORP | 2 | 2 | 5.71% | 6.62% | 7.53% | Q3 2017 | Q4 2017 | 2 |
LCI | LANNET INC | 2 | 2 | 4.57% | 6.27% | 7.98% | Q3 2021 | Q4 2021 | 2 |
UHS | UNIVERSAL HLTH SVCS INC | 2 | 2 | 5.74% | 5.96% | 6.19% | Q4 2020 | Q1 2021 | 2 |
BDSI | BIODELIVERY SCIENCES I... | 2 | 2 | 4.38% | 5.30% | 6.23% | Q4 2020 | Q1 2021 | 2 |
ZGNX | ZOGENIX INC | 2 | 2 | 4.47% | 4.74% | 5.01% | Q3 2021 | Q4 2021 | 2 |
LLY | LILLY ELI & CO | 1 | 1 | 0.24% | 2.97% | 5.70% | Q4 2017 | Q4 2022 | 2 |
SCLN | SCICLONE PHARMACEUTICA... | 1 | 1 | 0.68% | 0.95% | 1.22% | Q4 2013 | Q1 2016 | 2 |
CEMI | Chembio Diagnostics Inc | 2 | 2 | 0.20% | 0.24% | 0.28% | Q4 2013 | Q1 2014 | 2 |
GSK PLC | 1 | 1 | 10.18% | 10.18% | 10.18% | Q4 2022 | Q4 2022 | 1 | |
OSIR | OSIRIS THERAPEUTICS IN... | 1 | 1 | 8.39% | 8.39% | 8.39% | Q1 2017 | Q1 2017 | 1 |
MYGN | Myriad Genetics Inc | 1 | 1 | 7.89% | 7.89% | 7.89% | Q4 2013 | Q4 2013 | 1 |
COLL | COLLEGIUM PHARMACEUTIC... | 1 | 1 | 6.37% | 6.37% | 6.37% | Q4 2020 | Q4 2020 | 1 |
UTHR | UNITED THERAPEUTICS CO... | 1 | 1 | 6.13% | 6.13% | 6.13% | Q1 2021 | Q1 2021 | 1 |
DGX | QUEST DIAGNOSTICS INC | 1 | 1 | 5.92% | 5.92% | 5.92% | Q4 2017 | Q4 2017 | 1 |
TEVA | TEVA PHARMACEUTICAL IN... | 1 | 1 | 5.85% | 5.85% | 5.85% | Q4 2020 | Q4 2020 | 1 |
ELOS | SYNERON MEDICAL LTD | 1 | 1 | 5.46% | 5.46% | 5.46% | Q4 2016 | Q4 2016 | 1 |
CXRXF | CONCORDIA INTL CORP | 1 | 1 | 5.36% | 5.36% | 5.36% | Q2 2016 | Q2 2016 | 1 |
INSYQ | INSYS THERAPEUTICS INC... | 1 | 1 | 4.68% | 4.68% | 4.68% | Q2 2016 | Q2 2016 | 1 |
VRX | VALEANT PHARMACEUTICAL... | 1 | 1 | 4.56% | 4.56% | 4.56% | Q1 2016 | Q1 2016 | 1 |
ATRS | ANTARES PHARMA INC | 1 | 1 | 4.54% | 4.54% | 4.54% | Q4 2020 | Q4 2020 | 1 |
ICPT | INTERCEPT PHARMACEUTIC... | 1 | 1 | 4.20% | 4.20% | 4.20% | Q4 2021 | Q4 2021 | 1 |
ALDX | ALDEYRA THERAPEUTICS INC | 1 | 1 | 4.08% | 4.08% | 4.08% | Q3 2021 | Q3 2021 | 1 |
CPRX | CATALYST PHARMACEUTICA... | 1 | 1 | 3.87% | 3.87% | 3.87% | Q4 2020 | Q4 2020 | 1 |
EOLS | EVOLUS INC | 1 | 1 | 3.42% | 3.42% | 3.42% | Q3 2021 | Q3 2021 | 1 |
ACHN | ACHILLION PHARMACEUTIC... | 1 | 1 | 3.21% | 3.21% | 3.21% | Q1 2017 | Q1 2017 | 1 |
BCR | Bard C R Inc | 1 | 1 | 2.93% | 2.93% | 2.93% | Q4 2013 | Q4 2013 | 1 |
URGN | UROGEN PHARMA LTD | 1 | 1 | 1.89% | 1.89% | 1.89% | Q3 2021 | Q3 2021 | 1 |
PGNX | PROGENICS PHARMACEUTIC... | 1 | 1 | 1.32% | 1.32% | 1.32% | Q3 2016 | Q3 2016 | 1 |
DEPO | DEPOMED INC | 1 | 1 | 1.30% | 1.30% | 1.30% | Q1 2016 | Q1 2016 | 1 |
ATEC | ALPHATEC HOLDINGS INC | 1 | 1 | 1.26% | 1.26% | 1.26% | Q4 2016 | Q4 2016 | 1 |
CUTR | Cutera Inc | 1 | 1 | 0.87% | 0.87% | 0.87% | Q4 2013 | Q4 2013 | 1 |
BIL | SPDR SERIES TRUST | 1 | 1 | 0.68% | 0.68% | 0.68% | Q3 2016 | Q3 2016 | 1 |
SHY | ISHARES TR | 1 | 1 | 0.63% | 0.63% | 0.63% | Q3 2016 | Q3 2016 | 1 |
UNH | UNITEDHEALTH GROUP INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2022 | Q4 2022 | 1 |
TMO | THERMO FISHER SCIENTIF... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2022 | Q4 2022 | 1 |
REGN | REGENERON PHARMACEUTICALS | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2022 | Q4 2022 | 1 |
BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2022 | Q4 2022 | 1 |
SYK | STRYKER CORPORATION | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2022 | Q4 2022 | 1 |
IQV | IQVIA HLDGS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2022 | Q4 2022 | 1 |
BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2022 | Q4 2022 | 1 |
DXCM | DEXCOM INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2022 | Q4 2022 | 1 |
MRNA | MODERNA INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2022 | Q4 2022 | 1 |
RPRX | ROYALTY PHARMA PLC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2022 | Q4 2022 | 1 |
EW | EDWARDS LIFESCIENCES CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2022 | Q4 2022 | 1 |
NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
MASI | MASIMO CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
OPCH | OPTION CARE HEALTH INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
CYTK | CYTOKINETICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
DOCS | DOXIMITY INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 |
ITCI | INTRA-CELLULAR THERAPI... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 |
RXDX | PROMETHEUS BIOSCIENCES... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 |
EXAS | EXACT SCIENCES CORP | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 |
INSP | INSPIRE MED SYS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
KRYS | KRYSTAL BIOTECH INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
AKRO | AKERO THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
BLU | BELLUS HEALTH INC NEW | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
OM | OUTSET MED INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
PRTA | PROTHENA CORP PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
BBIO | BRIDGEBIO PHARMA INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
FOLD | AMICUS THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
BCYC | BICYCLE THERAPEUTICS PLC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
SWAV | SHOCKWAVE MED INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
KRTX | KARUNA THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
MRVI | MARAVAI LIFESCIENCES H... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
IMGN | IMUNOGEN INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
PSTX | POSEIDA THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
MRUS | MERUS N V | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
ARCELLX INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 | |
DNLI | DENALI THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
Download |
The securities at the top of the list , including CHARLES RIV LABS INTL INC, GILEAD SCIENCES INC, and CARDINAL HEALTH INC, are the highest-conviction holdings of HealthInvest Partners AB.
The conviction is calculated by counting the number of quarters a security has been reported by HealthInvest Partners AB. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that HealthInvest Partners AB owns currently or has owned in the past.